Prescription Required
Hdyshil 500mg Tablet is an antineoplastic and cytotoxic medication used in the treatment of sickle cell anemia, certain cancers, and other blood disorders. It helps manage symptoms, reduces complications, and improves quality of life by controlling abnormal cell growth and promoting healthier blood parameters.
Patients with liver impairment should use this medication cautiously. Regular monitoring of liver enzymes may be required to avoid complications.
Hydroxyurea is excreted through the kidneys, so patients with kidney impairment may require dose adjustments to avoid toxicity.
Avoid alcohol consumption while using Hdyshil 500mg Tablet, as it may worsen nausea, dizziness, or fatigue associated with the medication.
Avoid driving or operating heavy machinery if you experience dizziness or fatigue as a side effect of the medication.
Hdyshil 500mg Tablet is not recommended during pregnancy due to the risk of harm to the fetus. Effective contraception is advised for both men and women during treatment.
This medication should not be used while breastfeeding, as it may pass into breast milk and cause harm to the infant.
Hydroxyurea, the active ingredient in Hdyshil 500mg Tablet, works by interfering with DNA synthesis in rapidly dividing cells. In sickle cell anemia, it increases fetal hemoglobin production, which reduces the formation of sickle-shaped cells. For cancer, it slows the growth and spread of cancer cells, alleviating symptoms and improving patient outcomes.
Sickle cell anemia is a genetic blood disorder that causes abnormally shaped red blood cells, leading to blockages and poor oxygen delivery. In cancer, abnormal cell growth can result in tumors or metastasis.
Content Updated on
Thursday, 28 November, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA